These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19553547)

  • 1. Propionic acid secreted from propionibacteria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells.
    Andresen L; Hansen KA; Jensen H; Pedersen SF; Stougaard P; Hansen HR; Jurlander J; Skov S
    J Immunol; 2009 Jul; 183(2):897-906. PubMed ID: 19553547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of short-chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells.
    Høgh RI; Møller SH; Jepsen SD; Mellergaard M; Lund A; Pejtersen M; Fitzner E; Andresen L; Skov S
    FASEB J; 2020 Nov; 34(11):15531-15546. PubMed ID: 32996653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
    Andresen L; Skovbakke SL; Persson G; Hagemann-Jensen M; Hansen KA; Jensen H; Skov S
    J Immunol; 2012 Feb; 188(4):1847-55. PubMed ID: 22227571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol-dependent expression of the NKG2D ligands MICA/B in human cell lines and leukocytes.
    Streltsova MA; Klinkova AV; Kuchukova AA; Kadin AY; Kanevskiy LM; Kovalenko EI
    Biochem Cell Biol; 2017 Apr; 95(2):280-288. PubMed ID: 28177768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells.
    Møller SH; Mellergaard M; Madsen M; Bermejo AV; Jepsen SD; Hansen MH; Høgh RI; Aldana BI; Desler C; Rasmussen LJ; Sustarsic EG; Gerhart-Hines Z; Daskalaki E; Wheelock CE; Hiron TK; Lin D; O'Callaghan CA; Wandall HH; Andresen L; Skov S
    Front Immunol; 2020; 11():1968. PubMed ID: 32849657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer.
    Xu X; Rao G; Gaffud MJ; Ding HG; Maki G; Klingemann HG; Groh V; Spies T; Caillat-Zucman S; Gattuso P; Plate J; Prinz RA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2704-12. PubMed ID: 16621903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.
    Okita R; Mougiakakos D; Ando T; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kiessling R
    J Immunol; 2012 Mar; 188(5):2136-45. PubMed ID: 22301547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells.
    Nakajima NI; Niimi A; Isono M; Oike T; Sato H; Nakano T; Shibata A
    Oncol Rep; 2017 Aug; 38(2):693-702. PubMed ID: 28677817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.
    Bedel R; Thiery-Vuillemin A; Grandclement C; Balland J; Remy-Martin JP; Kantelip B; Pallandre JR; Pivot X; Ferrand C; Tiberghien P; Borg C
    Cancer Res; 2011 Mar; 71(5):1615-26. PubMed ID: 21257710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2.
    Uhlenbrock F; van Andel E; Andresen L; Skov S
    Mol Immunol; 2015 Aug; 66(2):418-27. PubMed ID: 25983110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
    Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
    Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells.
    Andresen L; Jensen H; Pedersen MT; Hansen KA; Skov S
    J Immunol; 2007 Dec; 179(12):8235-42. PubMed ID: 18056367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
    Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
    J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class I chain-related gene A polymorphism and linkage disequilibrium with HLA-B alleles in Euro-Brazilians.
    Ribas F; Oliveira LA; Petzl-Erler ML; Bicalho MG
    Tissue Antigens; 2008 Dec; 72(6):532-8. PubMed ID: 19000131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity.
    Molinero LL; Domaica CI; Fuertes MB; Girart MV; Rossi LE; Zwirner NW
    Hum Immunol; 2006 Mar; 67(3):170-82. PubMed ID: 16698439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.
    Kato N; Tanaka J; Sugita J; Toubai T; Miura Y; Ibata M; Syono Y; Ota S; Kondo T; Asaka M; Imamura M
    Leukemia; 2007 Oct; 21(10):2103-8. PubMed ID: 17625602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28.
    Molinero LL; Fuertes MB; Rabinovich GA; Fainboim L; Zwirner NW
    J Leukoc Biol; 2002 May; 71(5):791-7. PubMed ID: 11994503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MICA antigens stimulate T cell proliferation and cell-mediated cytotoxicity.
    Zhang Y; Stastny P
    Hum Immunol; 2006 Mar; 67(3):215-22. PubMed ID: 16698445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.